LFCR

LFCR

LFCRNYSE / NASDAQ

$6.39+$0.02 (+0.3%)

Last close · Data as of Nov 20, 2026

A period is left blank when the price history is shorter than the period.

LFCR price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
+0.3%
3M
+41.4%
6M
+39.8%
1Y
Short history
5Y
Short history
  • A period is left blank when the price history is shorter than the period.

52-week range

Day change +$0.02 (+0.3%) from $6.37 to $6.39 · Last close Nov 20, 2026

News & filings

What LFCR filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

No rule stands out for this company on the data on file as of 20 Nov 2026.

  • Financial statements for this company are not on file.

Prices to the 20 Nov 2026 close

Rule-based from financial data. Not advice.

About the company

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally.

Read moreShow less

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

52-week high
$6.59
52-week low
$4.09

Growth

No growth data available.

No growth data available.

Monthly returns

Month-by-month returns of LFCR across the years, with the seasonal pattern.

Market cap against peers

8 peers: same sector, nearest by size.

P/E against peers

Most of this group is loss-making, so EV / Sales is compared for the companies without a P/E.

EV / Sales, for the companies without earnings

Not shown (no positive earnings and no EV / Sales): LFCR, Tvardi Therapeutics, Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
LFCRLFCRthis company—————
INmune Bio Inc.INMB$35.9M-0.8x1.5x-195.3%-0.4x
Neonode Inc.NEON$31.0M3.7x1.3x34.4%0.8x
Tvardi Therapeutics, Inc.TVRD$28.9M-1.6x1.4x-87.0%-0.3x
GoHealth, Inc.GOCO$21.4M-0.1x0.6x-678.9%-2.0x
Sleep Number CorporationSNBR$8.1M——22.8%105.2x
zSpace, Inc.ZSPC$959.7k-0.0x-0.0x112.8%-0.8x
Trinseo PLCTSEOF$475.3k-0.0x-0.0x49.7%39.4x
ACCO Brands CorporationACCO$0.000.0x0.0x6.2%5.1x
Peer median—-0.0x0.6x14.5%0.2x

Year-to-date ROI

LFCR since 1 January, against earlier years.

Historical volatility

LFCR's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

No financial statement data available.

Learn while you research

Academy chapters picked for LFCR and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  3. 03 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →